End Stage Renal Disease on Dialysis Clinical Trials

12 recruiting

End Stage Renal Disease on Dialysis Trials at a Glance

13 actively recruiting trials for end stage renal disease on dialysis are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Bielefeld, and Bristol. Lead sponsors running end stage renal disease on dialysis studies include Cardenal Herrera University, Chinese University of Hong Kong, and Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari.

Browse end stage renal disease on dialysis trials by phase

Treatments under study

About End Stage Renal Disease on Dialysis Clinical Trials

Looking for clinical trials for End Stage Renal Disease on Dialysis? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new End Stage Renal Disease on Dialysis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about End Stage Renal Disease on Dialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

End Stage Renal Disease on Dialysis
University of California, Los Angeles90 enrolled2 locationsNCT05654103
Recruiting
Not Applicable

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

End Stage Renal Disease on Dialysis
University of Illinois at Chicago40 enrolled1 locationNCT07014111
Recruiting
Not Applicable

Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)

End Stage Renal Disease on Dialysis
Peking University People's Hospital34 enrolled1 locationNCT07111260
Recruiting
Phase 2

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationResidual Kidney Function+1 more
Chinese University of Hong Kong48 enrolled1 locationNCT06483074
Recruiting

Registry of GORE® ACUSEAL Vascular Graft in Dialysis Access

Chronic Kidney DiseasesEnd Stage Renal Disease on Dialysis
W.L.Gore & Associates72 enrolled5 locationsNCT05846581
Recruiting

Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins

End Stage Renal Disease on Dialysis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine120 enrolled1 locationNCT07016841
Recruiting
Phase 4

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

End Stage Renal Disease on Dialysis
Yale University30 enrolled1 locationNCT05671991
Recruiting
Phase 4

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

End Stage Renal Disease on DialysisHeart Failure With Preserved Ejection Fraction
National Taiwan University Hospital150 enrolled2 locationsNCT06249945
Recruiting

Targeted Deprescribing in Patients on Hemodialysis

End Stage Renal Disease on Dialysis (Diagnosis)
University Health Network, Toronto480 enrolled4 locationsNCT03733262
Recruiting
Not Applicable

Virtual Reality Intradialysis: Last vs. First Part of the Session

Hemodialysis ComplicationEnd Stage Renal Disease on Dialysis
Cardenal Herrera University50 enrolled1 locationNCT04046042
Recruiting
Not Applicable

RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)

End Stage Renal Disease on Dialysis
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari190 enrolled1 locationNCT04360694
Recruiting
Not Applicable

Study on the Influence of Dyadic Psychoeducational Intervention on Patients With Maintenance Hemodialysis

End Stage Renal Disease on Dialysis
Jiangsu Taizhou People's Hospital80 enrolled1 locationNCT06203730
Recruiting
Not Applicable

HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis

End Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Failure on Dialysis
Nanyang Technological University148 enrolled1 locationNCT04774770